Skip to content

Membranoproliferative Glomerulonephritis X Linked C1844501

Published: July 22, 2026Updated: August 20, 2026

A chronic kidney disease where the filtering units become inflamed and damaged over time. Can progress to kidney failure requiring dialysis or transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hematuria

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Proteinuria

(renal)

Hypertension

(cardiovascular)

Edema

(systemic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunosuppressive therapy

Corticosteroids and other immunosuppressants are often used as first-line treatment to reduce glomerular inflammation and slow disease progression in X-linked membranoproliferative glomerulonephritis.

medication
2

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Renin-angiotensin system blockade

ACE inhibitors or ARBs to reduce proteinuria and provide renal protection. These agents help decrease intraglomerular pressure and slow disease progression.

medication

Additional treatment options

Kidney-protective dietary management

Sodium restriction and protein modification to reduce glomerular hyperfiltration. May include phosphorus and potassium modifications based on laboratory findings.

dietary

Renal function and proteinuria surveillance

Regular monitoring of serum creatinine, estimated GFR, urine protein-to-creatinine ratio, and complement levels to assess disease activity and treatment response.

monitoring

Kidney biopsy for definitive diagnosis

Renal biopsy provides definitive diagnosis, identifies histologic patterns, and guides treatment intensity. Essential for confirming the specific type of MPGN and activity level.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Membranoproliferative Glomerulonephritis X Linked C1844501?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Membranoproliferative Glomerulonephritis X Linked C1844501. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy